Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:27 pm Purchase | 2021-12-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Point72 Asset Management, L.P. | 2,657,962 5.300% | 107,226 (+4.20%) | Filing History |
| 2022-02-14 4:26 pm Purchase | 2021-12-31 | 13G | AKERO THERAPEUTICS INC AKRO | Point72 Asset Management, L.P. | 1,760,248 5.000% | 8,685 (+0.50%) | Filing History |
| 2022-02-14 4:25 pm Sale | 2021-12-31 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Point72 Asset Management, L.P. | 2,244 0.100% | -114,947 (-98.09%) | Filing History |
| 2022-02-11 5:05 pm Purchase | 2022-02-01 | 13G | UNIQURE N V QURE | Point72 Asset Management, L.P. | 3,611,691 7.800% | 3,143,854 (+672.00%) | Filing History |
| 2022-02-10 5:07 pm Purchase | 2022-01-31 | 13G | FIBROGEN INC FGEN | Point72 Asset Management, L.P. | 186,644 5.000% | 186,644 (New Position) | Filing History |
| 2022-01-10 4:52 pm Purchase | 2022-01-07 | 13G | BELLRING BRANDS INC BRBR | Point72 Asset Management, L.P. | 1,983,182 5.100% | 1,983,182 (New Position) | Filing History |
| 2022-01-04 5:20 pm Purchase | 2022-01-03 | 13G | APPLIED THERAPEUTICS INC APLT | Point72 Asset Management, L.P. | 2,556,976 9.800% | 2,556,976 (New Position) | Filing History |
| 2021-12-21 5:13 pm Purchase | 2021-12-20 | 13G | ATARA BIOTHERAPEUTICS INC ATRA | Point72 Asset Management, L.P. | 182,721 5.200% | 182,721 (New Position) | Filing History |
| 2021-12-15 5:14 pm Purchase | 2021-12-14 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Point72 Asset Management, L.P. | 2,550,736 5.100% | 2,550,736 (New Position) | Filing History |
| 2021-12-13 4:58 pm Purchase | 2021-12-10 | 13G | AKERO THERAPEUTICS INC AKRO | Point72 Asset Management, L.P. | 1,751,563 5.000% | 1,751,563 (New Position) | Filing History |
| 2021-12-06 5:22 pm Purchase | 2021-12-03 | 13G | KRYSTAL BIOTECH INC KRYS | Point72 Asset Management, L.P. | 1,343,242 5.400% | 1,343,242 (New Position) | Filing History |
| 2021-11-17 5:27 pm Purchase | 2021-11-09 | 13G | X4 PHARMACEUTICALS INC XFOR | Point72 Asset Management, L.P. | 50,008 5.600% | 50,008 (New Position) | Filing History |
| 2021-10-28 5:24 pm Purchase | 2021-10-27 | 13G | XENON PHARMACEUTICALS INC XENE | Point72 Asset Management, L.P. | 2,641,253 5.100% | 2,641,253 (New Position) | Filing History |
| 2021-10-28 5:05 pm Purchase | 2021-10-18 | 13G | OYSTER PT PHARMA INC OYST | Point72 Asset Management, L.P. | 2,297,761 8.800% | 2,297,761 (New Position) | Filing History |
| 2021-10-14 5:12 pm Purchase | 2021-10-13 | 13G | CIDARA THERAPEUTICS INC CDTX | Point72 Asset Management, L.P. | 210,000 6.300% | 210,000 (New Position) | Filing History |
| 2021-10-07 5:24 pm Purchase | 2021-10-06 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Point72 Asset Management, L.P. | 168,712 5.700% | 168,712 (New Position) | Filing History |
| 2021-09-21 4:51 pm Purchase | 2021-09-17 | 13G | AVALO THERAPEUTICS INC AVTX | Point72 Asset Management, L.P. | 2,087 5.400% | 2,087 (New Position) | Filing History |
| 2021-09-21 4:34 pm Purchase | 2021-09-20 | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | Point72 Asset Management, L.P. | 4,329,030 9.100% | 4,329,030 (New Position) | Filing History |
| 2021-09-13 4:56 pm Purchase | 2021-09-10 | 13G | GROWTH CAP ACQUISITION CORP GCAC | Point72 Asset Management, L.P. | 1,080,424 6.300% | 1,080,424 (New Position) | Filing History |
| 2021-09-07 4:35 pm Purchase | 2021-08-25 | 13G | THERAVANCE BIOPHARMA INC TBPH | Point72 Asset Management, L.P. | 5,144,637 7.000% | 5,144,637 (New Position) | Filing History |